NNMT and nonpapillary renal cell carcinoma: Indeed, dual inhibition of NNMT (using the inhibitor NNMTi23) and glycolysis in both ccRCC cell lines (786‐O and A498) and two 2D ccRCC primary models derived from tumour (RCC2) and metastasis (RCC1) led to strongly decreased cell viability.